Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the filing of a ...
CHICAGO, IL / ACCESS Newswire / February 5, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovativ ...
(RTTNews) - Polyrizon Ltd. (PLRZ), a development-stage biotech company, has filed a divisional patent application with the Israel Patent Office for its Trap & Target or T&T intranasal drug ...